Last reviewed · How we verify

Bharat Serums and Vaccines Limited — Portfolio Competitive Intelligence Brief

Bharat Serums and Vaccines Limited pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Amphotericin B Lipid emulsion Amphotericin B Lipid emulsion phase 3 Polyene antifungal Ergosterol Infectious Disease

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 1 shared drug class
  2. CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · 1 shared drug class
  3. Dr. Falk Pharma GmbH · 1 shared drug class
  4. Drugs for Neglected Diseases · 1 shared drug class
  5. Federal University of Health Science of Porto Alegre · 1 shared drug class
  6. Fundacion Nacional de Dermatologia · 1 shared drug class
  7. Pfizer · 1 shared drug class
  8. Poitiers University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bharat Serums and Vaccines Limited:

Cite this brief

Drug Landscape (2026). Bharat Serums and Vaccines Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bharat-serums-and-vaccines-limited. Accessed 2026-05-17.

Related